Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Geissler

Showing results (41-50 of 449) with videos related to

Pageof 45
Sort By:
Kidney International|September 24, 2010
The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantationEdward K Geissler, Hans J Schlitt
Nature Reviews. Nephrology|October 29, 2010
Transplantation: can sirolimus prevent skin cancer in transplant recipients?Edward K Geissler, Hans J Schlitt
Current Opinion in Organ Transplantation|July 11, 2013
Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipientsEdward K Geissler, James A Hutchinson
Wiener Klinische Wochenschrift|October 13, 1989
[Interleukin-3: a preclinical study]P Valent, K Geissler, P Bettelheim
Lancet (London, England)|June 19, 2018
Immunological investigations empower transplant drug trialsEdward K Geissler, James A Hutchinson
Wiener Klinische Wochenschrift|January 1, 1994
[Therapy of Hodgkin's disease]K Geissler, J Friedl, I Hauser
The New England Journal of Medicine|July 15, 2000
Inhibition of megakaryopoiesis by Kell-related antibodiesT Wagner, G Bernaschek, K Geissler
Occupational and Environmental Medicine|August 17, 1999
Dose dependent reduction of erythroid progenitor cells and inappropriate erythropoietin response in exposure to lead: new aspects of anaemia induced by leadW Osterode, U Barnas, K Geissler
Gut|December 5, 2008
Immunosuppression for liver transplantationE K Geissler, H J Schlitt
Cancer Research|August 18, 2018
Extracellular Citrate and Cancer Metabolism-ResponseMaria E Mycielska, Edward K Geissler
Pageof 45

Showing results (41-50 of 449) with videos related to

Sort By:
Pageof 45
Kidney International|September 24, 2010
The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantationEdward K Geissler, Hans J Schlitt
Nature Reviews. Nephrology|October 29, 2010
Transplantation: can sirolimus prevent skin cancer in transplant recipients?Edward K Geissler, Hans J Schlitt
Current Opinion in Organ Transplantation|July 11, 2013
Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipientsEdward K Geissler, James A Hutchinson
Wiener Klinische Wochenschrift|October 13, 1989
[Interleukin-3: a preclinical study]P Valent, K Geissler, P Bettelheim
Lancet (London, England)|June 19, 2018
Immunological investigations empower transplant drug trialsEdward K Geissler, James A Hutchinson
Wiener Klinische Wochenschrift|January 1, 1994
[Therapy of Hodgkin's disease]K Geissler, J Friedl, I Hauser
The New England Journal of Medicine|July 15, 2000
Inhibition of megakaryopoiesis by Kell-related antibodiesT Wagner, G Bernaschek, K Geissler
Occupational and Environmental Medicine|August 17, 1999
Dose dependent reduction of erythroid progenitor cells and inappropriate erythropoietin response in exposure to lead: new aspects of anaemia induced by leadW Osterode, U Barnas, K Geissler
Gut|December 5, 2008
Immunosuppression for liver transplantationE K Geissler, H J Schlitt
Cancer Research|August 18, 2018
Extracellular Citrate and Cancer Metabolism-ResponseMaria E Mycielska, Edward K Geissler
Pageof 45